The global isothermal nucleic acid amplification technology market reached a value of US$ 2.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.9 Billion by 2027, exhibiting at a CAGR of 12.7% during 2022-2027.
Isothermal nucleic acid amplification technology (INAAT) is primarily deployed in the field of molecular biology for identifying and analyzing nucleic acids. It is majorly used for DNA, RNA, cell protein, ions, molecules, etc. Isothermal nucleic acid amplification technology (INAAT) is primarily deployed in the field of molecular biology for identifying and analyzing nucleic acids. It is majorly used for DNA, RNA, cell protein, ions, molecules, etc.
INAAT offers a rapid, sensitive, and accurate diagnosis of genetic as well as infectious ailments. It provides amplicons for producing various nucleic acids that are predominantly utilized in biosensing, bioimaging, and biomedicines. Furthermore, INAAT is also used for detecting several diseases, such as influenza, HIV, tuberculosis, chlamydia, and gonorrhea (CT/NG), Hepatitis A and B, etc. Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report,
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/isothermal-nucleic-acid-amplification-technology-market/requestsample
INAAT Market Trends:
The widespread of COVID-19 has led to the rapid shift from specialized laboratory equipment towards INAAT for coronavirus detection. Additionally, the high prevalence of several chronic diseases has augmented the demand for effective diagnosis and treatment procedures, which is propelling the market growth. The increasing popularity of INAAT in identifying genetically modified organisms (GMOs) is also catalyzing the market. Several technological advancements in the sector have led to the development of Recombinase Polymerase Amplification (RPA), Single Primer Isothermal Amplification (SPIA), and Strand Displacement Amplification (SDA). The rising investments in various R&D activities are anticipated to bolster the market for INAAT in the coming years.
Global Isothermal Nucleic Acid Amplification Technology/INAAT Market 2022-2027 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of the key players being Abbott Laboratories (NYSE: ABT), BIOMERIEUX (BIM.PA), BD (Becton, Dickinson and Company), Eiken Chemical Co. Ltd., Hologic Inc., Meridian Bioscience Inc., OptiGene Limited, Thermo Fisher Scientific Inc., Tecan Trading AG, Ustar Biotechnologies Ltd., etc.
For more information about this report visit: https://www.imarcgroup.com/isothermal-nucleic-acid-amplification-technology-market
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Contact US:
IMARC Group
30 N Gould St,
Ste R Sheridan, WY 82801,
USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com USA: +1-631-791-1145
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group
